T-cell Prolymphocytic Leukemia
📧 Sign up to get email alerts when something new happens for T-cell Prolymphocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2018-05-21Clinical Trial Update: Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia [Phase 2]
A Phase II trial of Velcade (bortezomib) for relapsed or refractory T-cell prolymphocytic leukemia has been withdrawn (sponsor: Stanford Uni…